أرسل هذا في رسالة قصيرة: Contribution of EGFR and ErbB-3 heterodimerization to the EGFR mutation-induced gefitinib- and erlotinib-resistance in non-small-cell lung carcinoma treatments

  ______    _____    _    _      ___    __    __  
 /_____//  |  ___|| | |  | ||   / _ \\  \ \\ / // 
 `____ `   | ||__   | |/\| ||  | / \ ||  \ \/ //  
 /___//    | ||__   |  /\  ||  | \_/ ||   \  //   
 `__ `     |_____|| |_// \_||   \___//     \//    
 /_//      `-----`  `-`   `-`   `---`       `     
 `-`